These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27185805)

  • 1. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M; Clabots C; Porter SB; Thuras P; Johnson JR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4638-45. PubMed ID: 27185805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-
    Johnson JR; Porter S; Thuras P; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras P; Johnson JR
    PLoS One; 2018; 13(7):e0200442. PubMed ID: 29990385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
    Colpan A; Johnston B; Porter S; Clabots C; Anway R; Thao L; Kuskowski MA; Tchesnokova V; Sokurenko EV; Johnson JR;
    Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras PD; Johnson JR
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115034. PubMed ID: 32331800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
    mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence of ESBL-Producing
    Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Rogers BA; Ingram PR; Runnegar N; Pitman MC; Freeman JT; Athan E; Havers S; Sidjabat HE; Gunning E; De Almeida M; Styles K; Paterson DL;
    Int J Antimicrob Agents; 2015 Apr; 45(4):351-8. PubMed ID: 25707371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pandemic
    Johnson JR; Porter S; Thuras P; Castanheira M
    Open Forum Infect Dis; 2017; 4(2):ofx089. PubMed ID: 28638846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
    Nicolas-Chanoine MH; Petitjean M; Mora A; Mayer N; Lavigne JP; Boulet O; Leflon-Guibout V; Blanco J; Hocquet D
    BMC Microbiol; 2017 Mar; 17(1):71. PubMed ID: 28347271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.
    Lafolie J; Nicolas-Chanoine MH; Grenouillet F; Hocquet D; Bertrand X
    Int J Antimicrob Agents; 2014 Nov; 44(5):466-8. PubMed ID: 25241262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.